- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
The Measles Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Measles Vaccine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Children accounting for % of the Measles Vaccine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Mumps Measles Rubella Vaccine, Live (MMR-II) segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Measles Vaccine include GSK, Sanofi-Pasteur, Merck, Novartis, and Pfizer, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Measles Vaccine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Mumps Measles Rubella Vaccine, Live (MMR-II)
Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
Market segment by Application can be divided into
Children
Adults
The key market players for global Measles Vaccine market are listed below:
GSK
Sanofi-Pasteur
Merck
Novartis
Pfizer
Serum Institute of India
China National Biotech Group
Bavarian Nordic
Emergent Biosolutions
Medimmune
Johnson & Johnson
CSL Limited
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Measles Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Measles Vaccine, with price, sales, revenue and global market share of Measles Vaccine from 2019 to 2022.
Chapter 3, the Measles Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Measles Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Measles Vaccine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Measles Vaccine.
Chapter 13, 14, and 15, to describe Measles Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Measles Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Measles Vaccine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Mumps Measles Rubella Vaccine, Live (MMR-II)
1.2.3 Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
1.3 Market Analysis by Application
1.3.1 Overview: Global Measles Vaccine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Children
1.3.3 Adults
1.4 Global Measles Vaccine Market Size & Forecast
1.4.1 Global Measles Vaccine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Measles Vaccine Sales in Volume (2017-2028)
1.4.3 Global Measles Vaccine Price (2017-2028)
1.5 Global Measles Vaccine Production Capacity Analysis
1.5.1 Global Measles Vaccine Total Production Capacity (2017-2028)
1.5.2 Global Measles Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Measles Vaccine Market Drivers
1.6.2 Measles Vaccine Market Restraints
1.6.3 Measles Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Measles Vaccine Product and Services
2.1.4 GSK Measles Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Sanofi-Pasteur
2.2.1 Sanofi-Pasteur Details
2.2.2 Sanofi-Pasteur Major Business
2.2.3 Sanofi-Pasteur Measles Vaccine Product and Services
2.2.4 Sanofi-Pasteur Measles Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Measles Vaccine Product and Services
2.3.4 Merck Measles Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis Measles Vaccine Product and Services
2.4.4 Novartis Measles Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer Measles Vaccine Product and Services
2.5.4 Pfizer Measles Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Serum Institute of India
2.6.1 Serum Institute of India Details
2.6.2 Serum Institute of India Major Business
2.6.3 Serum Institute of India Measles Vaccine Product and Services
2.6.4 Serum Institute of India Measles Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 China National Biotech Group
2.7.1 China National Biotech Group Details
2.7.2 China National Biotech Group Major Business
2.7.3 China National Biotech Group Measles Vaccine Product and Services
2.7.4 China National Biotech Group Measles Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Bavarian Nordic
2.8.1 Bavarian Nordic Details
2.8.2 Bavarian Nordic Major Business
2.8.3 Bavarian Nordic Measles Vaccine Product and Services
2.8.4 Bavarian Nordic Measles Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Emergent Biosolutions
2.9.1 Emergent Biosolutions Details
2.9.2 Emergent Biosolutions Major Business
2.9.3 Emergent Biosolutions Measles Vaccine Product and Services
2.9.4 Emergent Biosolutions Measles Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Medimmune
2.10.1 Medimmune Details
2.10.2 Medimmune Major Business
2.10.3 Medimmune Measles Vaccine Product and Services
2.10.4 Medimmune Measles Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Johnson & Johnson
2.11.1 Johnson & Johnson Details
2.11.2 Johnson & Johnson Major Business
2.11.3 Johnson & Johnson Measles Vaccine Product and Services
2.11.4 Johnson & Johnson Measles Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 CSL Limited
2.12.1 CSL Limited Details
2.12.2 CSL Limited Major Business
2.12.3 CSL Limited Measles Vaccine Product and Services
2.12.4 CSL Limited Measles Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Measles Vaccine Breakdown Data by Manufacturer
3.1 Global Measles Vaccine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Measles Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Measles Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Measles Vaccine Manufacturer Market Share in 2021
3.4.2 Top 6 Measles Vaccine Manufacturer Market Share in 2021
3.5 Global Measles Vaccine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Measles Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Measles Vaccine Market Size by Region
4.1.1 Global Measles Vaccine Sales in Volume by Region (2017-2028)
4.1.2 Global Measles Vaccine Revenue by Region (2017-2028)
4.2 North America Measles Vaccine Revenue (2017-2028)
4.3 Europe Measles Vaccine Revenue (2017-2028)
4.4 Asia-Pacific Measles Vaccine Revenue (2017-2028)
4.5 South America Measles Vaccine Revenue (2017-2028)
4.6 Middle East and Africa Measles Vaccine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Measles Vaccine Sales in Volume by Type (2017-2028)
5.2 Global Measles Vaccine Revenue by Type (2017-2028)
5.3 Global Measles Vaccine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Measles Vaccine Sales in Volume by Application (2017-2028)
6.2 Global Measles Vaccine Revenue by Application (2017-2028)
6.3 Global Measles Vaccine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Measles Vaccine Sales by Type (2017-2028)
7.2 North America Measles Vaccine Sales by Application (2017-2028)
7.3 North America Measles Vaccine Market Size by Country
7.3.1 North America Measles Vaccine Sales in Volume by Country (2017-2028)
7.3.2 North America Measles Vaccine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Measles Vaccine Sales by Type (2017-2028)
8.2 Europe Measles Vaccine Sales by Application (2017-2028)
8.3 Europe Measles Vaccine Market Size by Country
8.3.1 Europe Measles Vaccine Sales in Volume by Country (2017-2028)
8.3.2 Europe Measles Vaccine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Measles Vaccine Sales by Type (2017-2028)
9.2 Asia-Pacific Measles Vaccine Sales by Application (2017-2028)
9.3 Asia-Pacific Measles Vaccine Market Size by Region
9.3.1 Asia-Pacific Measles Vaccine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Measles Vaccine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Measles Vaccine Sales by Type (2017-2028)
10.2 South America Measles Vaccine Sales by Application (2017-2028)
10.3 South America Measles Vaccine Market Size by Country
10.3.1 South America Measles Vaccine Sales in Volume by Country (2017-2028)
10.3.2 South America Measles Vaccine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Measles Vaccine Sales by Type (2017-2028)
11.2 Middle East & Africa Measles Vaccine Sales by Application (2017-2028)
11.3 Middle East & Africa Measles Vaccine Market Size by Country
11.3.1 Middle East & Africa Measles Vaccine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Measles Vaccine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Measles Vaccine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Measles Vaccine
12.3 Measles Vaccine Production Process
12.4 Measles Vaccine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Measles Vaccine Typical Distributors
13.3 Measles Vaccine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Measles Vaccine Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Measles Vaccine Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. GSK Basic Information, Manufacturing Base and Competitors
Table 4. GSK Major Business
Table 5. GSK Measles Vaccine Product and Services
Table 6. GSK Measles Vaccine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Sanofi-Pasteur Basic Information, Manufacturing Base and Competitors
Table 8. Sanofi-Pasteur Major Business
Table 9. Sanofi-Pasteur Measles Vaccine Product and Services
Table 10. Sanofi-Pasteur Measles Vaccine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Merck Basic Information, Manufacturing Base and Competitors
Table 12. Merck Major Business
Table 13. Merck Measles Vaccine Product and Services
Table 14. Merck Measles Vaccine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Novartis Basic Information, Manufacturing Base and Competitors
Table 16. Novartis Major Business
Table 17. Novartis Measles Vaccine Product and Services
Table 18. Novartis Measles Vaccine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Pfizer Basic Information, Manufacturing Base and Competitors
Table 20. Pfizer Major Business
Table 21. Pfizer Measles Vaccine Product and Services
Table 22. Pfizer Measles Vaccine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 24. Serum Institute of India Major Business
Table 25. Serum Institute of India Measles Vaccine Product and Services
Table 26. Serum Institute of India Measles Vaccine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. China National Biotech Group Basic Information, Manufacturing Base and Competitors
Table 28. China National Biotech Group Major Business
Table 29. China National Biotech Group Measles Vaccine Product and Services
Table 30. China National Biotech Group Measles Vaccine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Bavarian Nordic Basic Information, Manufacturing Base and Competitors
Table 32. Bavarian Nordic Major Business
Table 33. Bavarian Nordic Measles Vaccine Product and Services
Table 34. Bavarian Nordic Measles Vaccine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Emergent Biosolutions Basic Information, Manufacturing Base and Competitors
Table 36. Emergent Biosolutions Major Business
Table 37. Emergent Biosolutions Measles Vaccine Product and Services
Table 38. Emergent Biosolutions Measles Vaccine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Medimmune Basic Information, Manufacturing Base and Competitors
Table 40. Medimmune Major Business
Table 41. Medimmune Measles Vaccine Product and Services
Table 42. Medimmune Measles Vaccine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 44. Johnson & Johnson Major Business
Table 45. Johnson & Johnson Measles Vaccine Product and Services
Table 46. Johnson & Johnson Measles Vaccine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. CSL Limited Basic Information, Manufacturing Base and Competitors
Table 48. CSL Limited Major Business
Table 49. CSL Limited Measles Vaccine Product and Services
Table 50. CSL Limited Measles Vaccine Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Global Measles Vaccine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K MT)
Table 52. Global Measles Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 53. Market Position of Manufacturers in Measles Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 54. Global Measles Vaccine Production Capacity by Company, (K MT): 2020 VS 2021
Table 55. Head Office and Measles Vaccine Production Site of Key Manufacturer
Table 56. Measles Vaccine New Entrant and Capacity Expansion Plans
Table 57. Measles Vaccine Mergers & Acquisitions in the Past Five Years
Table 58. Global Measles Vaccine Sales by Region (2017-2022) & (K MT)
Table 59. Global Measles Vaccine Sales by Region (2023-2028) & (K MT)
Table 60. Global Measles Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 61. Global Measles Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 62. Global Measles Vaccine Sales by Type (2017-2022) & (K MT)
Table 63. Global Measles Vaccine Sales by Type (2023-2028) & (K MT)
Table 64. Global Measles Vaccine Revenue by Type (2017-2022) & (USD Million)
Table 65. Global Measles Vaccine Revenue by Type (2023-2028) & (USD Million)
Table 66. Global Measles Vaccine Price by Type (2017-2022) & (USD/MT)
Table 67. Global Measles Vaccine Price by Type (2023-2028) & (USD/MT)
Table 68. Global Measles Vaccine Sales by Application (2017-2022) & (K MT)
Table 69. Global Measles Vaccine Sales by Application (2023-2028) & (K MT)
Table 70. Global Measles Vaccine Revenue by Application (2017-2022) & (USD Million)
Table 71. Global Measles Vaccine Revenue by Application (2023-2028) & (USD Million)
Table 72. Global Measles Vaccine Price by Application (2017-2022) & (USD/MT)
Table 73. Global Measles Vaccine Price by Application (2023-2028) & (USD/MT)
Table 74. North America Measles Vaccine Sales by Country (2017-2022) & (K MT)
Table 75. North America Measles Vaccine Sales by Country (2023-2028) & (K MT)
Table 76. North America Measles Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 77. North America Measles Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 78. North America Measles Vaccine Sales by Type (2017-2022) & (K MT)
Table 79. North America Measles Vaccine Sales by Type (2023-2028) & (K MT)
Table 80. North America Measles Vaccine Sales by Application (2017-2022) & (K MT)
Table 81. North America Measles Vaccine Sales by Application (2023-2028) & (K MT)
Table 82. Europe Measles Vaccine Sales by Country (2017-2022) & (K MT)
Table 83. Europe Measles Vaccine Sales by Country (2023-2028) & (K MT)
Table 84. Europe Measles Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 85. Europe Measles Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 86. Europe Measles Vaccine Sales by Type (2017-2022) & (K MT)
Table 87. Europe Measles Vaccine Sales by Type (2023-2028) & (K MT)
Table 88. Europe Measles Vaccine Sales by Application (2017-2022) & (K MT)
Table 89. Europe Measles Vaccine Sales by Application (2023-2028) & (K MT)
Table 90. Asia-Pacific Measles Vaccine Sales by Region (2017-2022) & (K MT)
Table 91. Asia-Pacific Measles Vaccine Sales by Region (2023-2028) & (K MT)
Table 92. Asia-Pacific Measles Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 93. Asia-Pacific Measles Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 94. Asia-Pacific Measles Vaccine Sales by Type (2017-2022) & (K MT)
Table 95. Asia-Pacific Measles Vaccine Sales by Type (2023-2028) & (K MT)
Table 96. Asia-Pacific Measles Vaccine Sales by Application (2017-2022) & (K MT)
Table 97. Asia-Pacific Measles Vaccine Sales by Application (2023-2028) & (K MT)
Table 98. South America Measles Vaccine Sales by Country (2017-2022) & (K MT)
Table 99. South America Measles Vaccine Sales by Country (2023-2028) & (K MT)
Table 100. South America Measles Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 101. South America Measles Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 102. South America Measles Vaccine Sales by Type (2017-2022) & (K MT)
Table 103. South America Measles Vaccine Sales by Type (2023-2028) & (K MT)
Table 104. South America Measles Vaccine Sales by Application (2017-2022) & (K MT)
Table 105. South America Measles Vaccine Sales by Application (2023-2028) & (K MT)
Table 106. Middle East & Africa Measles Vaccine Sales by Region (2017-2022) & (K MT)
Table 107. Middle East & Africa Measles Vaccine Sales by Region (2023-2028) & (K MT)
Table 108. Middle East & Africa Measles Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 109. Middle East & Africa Measles Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 110. Middle East & Africa Measles Vaccine Sales by Type (2017-2022) & (K MT)
Table 111. Middle East & Africa Measles Vaccine Sales by Type (2023-2028) & (K MT)
Table 112. Middle East & Africa Measles Vaccine Sales by Application (2017-2022) & (K MT)
Table 113. Middle East & Africa Measles Vaccine Sales by Application (2023-2028) & (K MT)
Table 114. Measles Vaccine Raw Material
Table 115. Key Manufacturers of Measles Vaccine Raw Materials
Table 116. Direct Channel Pros & Cons
Table 117. Indirect Channel Pros & Cons
Table 118. Measles Vaccine Typical Distributors
Table 119. Measles Vaccine Typical Customers
List of Figures
Figure 1. Measles Vaccine Picture
Figure 2. Global Measles Vaccine Revenue Market Share by Type in 2021
Figure 3. Mumps Measles Rubella Vaccine, Live (MMR-II)
Figure 4. Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)
Figure 5. Global Measles Vaccine Revenue Market Share by Application in 2021
Figure 6. Children
Figure 7. Adults
Figure 8. Global Measles Vaccine Revenue, (USD Million) & (K MT): 2017 & 2021 & 2028
Figure 9. Global Measles Vaccine Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Measles Vaccine Sales (2017-2028) & (K MT)
Figure 11. Global Measles Vaccine Price (2017-2028) & (USD/MT)
Figure 12. Global Measles Vaccine Production Capacity (2017-2028) & (K MT)
Figure 13. Global Measles Vaccine Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Measles Vaccine Market Drivers
Figure 15. Measles Vaccine Market Restraints
Figure 16. Measles Vaccine Market Trends
Figure 17. Global Measles Vaccine Sales Market Share by Manufacturer in 2021
Figure 18. Global Measles Vaccine Revenue Market Share by Manufacturer in 2021
Figure 19. Measles Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Measles Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Measles Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Measles Vaccine Sales Market Share by Region (2017-2028)
Figure 23. Global Measles Vaccine Revenue Market Share by Region (2017-2028)
Figure 24. North America Measles Vaccine Revenue (2017-2028) & (USD Million)
Figure 25. Europe Measles Vaccine Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Measles Vaccine Revenue (2017-2028) & (USD Million)
Figure 27. South America Measles Vaccine Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Measles Vaccine Revenue (2017-2028) & (USD Million)
Figure 29. Global Measles Vaccine Sales Market Share by Type (2017-2028)
Figure 30. Global Measles Vaccine Revenue Market Share by Type (2017-2028)
Figure 31. Global Measles Vaccine Price by Type (2017-2028) & (USD/MT)
Figure 32. Global Measles Vaccine Sales Market Share by Application (2017-2028)
Figure 33. Global Measles Vaccine Revenue Market Share by Application (2017-2028)
Figure 34. Global Measles Vaccine Price by Application (2017-2028) & (USD/MT)
Figure 35. North America Measles Vaccine Sales Market Share by Type (2017-2028)
Figure 36. North America Measles Vaccine Sales Market Share by Application (2017-2028)
Figure 37. North America Measles Vaccine Sales Market Share by Country (2017-2028)
Figure 38. North America Measles Vaccine Revenue Market Share by Country (2017-2028)
Figure 39. United States Measles Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Measles Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Measles Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Measles Vaccine Sales Market Share by Type (2017-2028)
Figure 43. Europe Measles Vaccine Sales Market Share by Application (2017-2028)
Figure 44. Europe Measles Vaccine Sales Market Share by Country (2017-2028)
Figure 45. Europe Measles Vaccine Revenue Market Share by Country (2017-2028)
Figure 46. Germany Measles Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Measles Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Measles Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Measles Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Measles Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Measles Vaccine Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Measles Vaccine Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Measles Vaccine Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Measles Vaccine Revenue Market Share by Region (2017-2028)
Figure 55. China Measles Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Measles Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Measles Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Measles Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Measles Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Measles Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Measles Vaccine Sales Market Share by Type (2017-2028)
Figure 62. South America Measles Vaccine Sales Market Share by Application (2017-2028)
Figure 63. South America Measles Vaccine Sales Market Share by Country (2017-2028)
Figure 64. South America Measles Vaccine Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Measles Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Measles Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Measles Vaccine Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Measles Vaccine Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Measles Vaccine Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Measles Vaccine Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Measles Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Measles Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Measles Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Measles Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Measles Vaccine in 2021
Figure 76. Manufacturing Process Analysis of Measles Vaccine
Figure 77. Measles Vaccine Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
